Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway
- 5 August 2025
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (9) , 100066
Abstract
No abstract availableKeywords
Funding Information
- Jinan University
- Natural Science Foundation of Guangdong Province (2022A151501636)
- Natural Science Foundation of Guangdong Province (20241515013257)
This publication has 35 references indexed in Scilit:
- EMT, cancer stem cells and autophagy; The three main axes of metastasisBiomedicine & Pharmacotherapy, 2021
- The role of alternative splicing in cancer: From oncogenesis to drug resistanceDrug Resistance Updates, 2020
- HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3′ UTREBioMedicine, 2019
- Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosisMedicinal Research Reviews, 2019
- HNRNPAB‐regulated lncRNA‐ELF209 inhibits the malignancy of hepatocellular carcinomaInternational Journal of Cancer, 2019
- SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistanceEBioMedicine, 2018
- Splicing factors of SR and hnRNP families as regulators of apoptosis in cancerCancer Letters, 2017
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- CArG box‐binding factor‐A interacts with multiple motifs in immunoglobulin promoters and has a regulated subcellular distributionEuropean Journal of Immunology, 2006
- A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressorGene, 1992